<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03088735</url>
  </required_header>
  <id_info>
    <org_study_id>SMD-2017-03</org_study_id>
    <nct_id>NCT03088735</nct_id>
  </id_info>
  <brief_title>Transfer Strategy in an Oocyte Donation Programme</brief_title>
  <official_title>Pilot Study of the Best Transfer Strategy in an Oocyte Donation Programme: an Intention to Treat Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Universitari Dexeus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Universitari Dexeus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been previously shown that although the activation of the embryonic genome can begin
      as early as two days of initiation of the embryonic development (D2), it is expressed on day
      3 (D3). Without this activation, the embryo can not continue its development. Therefore, it
      has been suggested that extended culture to blastocyst stage could be an option to identify
      and better select embryos that have been able to carry out this activation. The purpose of
      this study is to compare cumulative pregnancy and live birth rates following transfer of
      cleavage embryos or blastocysts.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative live birth rate</measure>
    <time_frame>at 12 months after a embryo transfer (time considered enough in order to do a minimum of one frozen-thawed cycle if pregnancy is not achieved with the fresh cycle</time_frame>
    <description>Total number of births considering fresh and frozen thawed embryos transferred</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative pregnancy rate</measure>
    <time_frame>at 12 months after a embryo transfer (time considered enough in order to do a minimum of one frozen-thawed cycle if pregnancy is not achieved with the fresh cycle</time_frame>
    <description>Total number of pregnancies confirmed by ultrasound 6 weeks after embryo transfer including fresh and thawed embryos.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Oocyte Donation</condition>
  <condition>Infertility, Female</condition>
  <condition>Embryo Transfer</condition>
  <arm_group>
    <arm_group_label>Blastocyst-stage embryo transfer strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cleavage-stage embryo transfer strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blastocyst-stage embryo transfer strategy</intervention_name>
    <description>Intra-uterine transfer of blastocist if in cleavage embryo stage the oocyte recipient has a m√≠nimum of 3 availables embryos with at least one of good quality to transfer and also the inta-uterine transfer of cleavage embryo (day 3) when the recipient doesn't have the previous criteria.</description>
    <arm_group_label>Blastocyst-stage embryo transfer strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cleavage-stage embryo transfer strategy</intervention_name>
    <description>Inta-uterine transferring of cleavage embryo transfer (day 3 of develpment) in oocyte recipients</description>
    <arm_group_label>Cleavage-stage embryo transfer strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients under their first or second cycle of a synchronous (fresh) oocyte donation
             cycle.

        Exclusion Criteria:

          -  Preimplantation genetic screening or diagnosis cycles.

          -  Patients with strict blastocyst-stage embryo transfer indication by the couple's
             treating physician.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elisabet Clua, PhD</last_name>
    <phone>0034932274700</phone>
    <phone_ext>22058</phone_ext>
    <email>eliclu@dexeus.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ignacio Rodriguez</last_name>
    <email>nacrod@dexeus.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department Obstetric, Gynecologic and Reproductive Medicine</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelons</state>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Rodriguez</last_name>
      <phone>0034932274700</phone>
      <phone_ext>22029</phone_ext>
      <email>nacrod@dexeus.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.dexeus.com</url>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2017</study_first_submitted>
  <study_first_submitted_qc>March 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2017</study_first_posted>
  <last_update_submitted>March 22, 2017</last_update_submitted>
  <last_update_submitted_qc>March 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Universitari Dexeus</investigator_affiliation>
    <investigator_full_name>Elisabet Clua Obrado</investigator_full_name>
    <investigator_title>Head of Gamete and Embryo Donation</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

